CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1 - sprookjes - yvandenbroek - TriplyDB

CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1

CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1

http://www.wikidata.org/entity/Q28251463

about

Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47 CD47 regulates bone mass and tumor metastasis to bone Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling The multifaceted role of the renal microvasculature during acute kidney injury Clinical lung xenotransplantation--what donor genetic modifications may be necessary?Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management Neurovascular effects of CD47 signaling: promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner The evolution of thrombospondins and their ligand-binding activities Thrombospondin-1 mediates multi-walled carbon nanotube induced impairment of arteriolar dilation Angiogenesis in bone regeneration.Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow.Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.Cardiac CD47 drives left ventricular heart failure through Ca2+-CaMKII-regulated induction of HDAC3.Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.Immunobiology of liver xenotransplantation.Molecular regulation of tumor angiogenesis and perfusion via redox signaling.CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis.E2F-1 directly regulates thrombospondin 1 expression.Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase.Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension Predictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissue Lack of thrombospondin 1 and exacerbation of choroidal neovascularization The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling.Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation CD47 signaling regulates the immunosuppressive activity of VEGF in T cells.Blockade of CD47 increases survival of mice exposed to lethal total body irradiation Elevated postinjury thrombospondin 1-CD47 triggering aids differentiation of patients' defective inflammatory CD1a+dendritic cells.Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow.Disruption of thrombospondin-2 accelerates ischemic fracture healing.

P2860

Q21245714-25B369FF-1CE1-49EE-ABC0-B90B4BD5F62D Q24302047-378D4D06-B4A2-409E-AD02-5369FBA8F096 Q24627155-5F504374-2CCD-401D-992F-99030159E295 Q24651925-AACF9111-548C-4284-97BA-8FB83F57EC8A Q24654057-C00C30B1-A1D4-4B22-BFDE-1AABAF9D6E7C Q24657627-34CF1C29-A057-45E7-9EFC-D9448BE9314A Q26780409-D05BCEA6-8A4C-4E88-93E6-4A135E303AA7 Q26823663-680231C1-D382-447A-9CBF-4A99260C3519 Q26864499-6CFAAA4C-99DC-4D9B-9523-C0B4168FC738 Q28240979-329DC783-3883-4409-B277-09580307792F Q28270624-52E684D2-2AD3-4943-9EB7-705A7D446EC3 Q28293417-ADAB5D40-F735-4833-9DCC-5CC6B89EF0D9 Q28476620-670AAF2F-7D7A-408C-801C-2AE2EADAA00C Q28744006-A66620A8-B65D-4298-A917-824556834F2C Q28917103-3CDA518E-6DAE-4845-BC46-631FCC3F3F4B Q30467055-D798E255-27EB-4FF4-A058-2AF1D6275B31 Q30482804-DA094EF9-3E86-4E6D-817C-97431FBE1C33 Q30503997-72A9AEC0-4283-4151-925B-290679685A41 Q30618651-B3C98894-55B5-4007-A2D6-F69E1E134295 Q33312205-D6E88180-E16D-4E33-A7A9-EE9D28EB97D9 Q33392798-B6B6C2B5-765F-4FA6-B6C7-6E99D22A34EC Q33403888-953F6DF0-EB24-4974-B822-5627867A26FA Q33572306-31CC1E11-F9A8-4F1C-B22E-5C34480F3C16 Q33618348-FC6E356F-D82B-4A0E-9184-2250AF67082A Q33728451-E6BFE6F9-399F-464F-8583-1E5D640702AF Q33745306-1CFA6B6A-C657-4799-877C-F3CF419D1756 Q33766507-233B9834-8088-4AF0-919C-9845CFEA2603 Q33772904-AEC19EBF-61C1-487D-930B-972C78213C70 Q33806253-577F5B59-3DDF-4F0D-ABC4-422AB68B43A4 Q33897971-E71C99C3-E661-4B26-B601-A8935A89B2F5 Q34122564-6AC78BDA-DAF0-42F2-9A3F-93718953FB3A Q34162333-5D93676B-46F9-46F4-8D57-A829354FB36D Q34275612-0A36A23B-D16A-4619-B22D-01F50D316E1A Q34289358-1CFE70C4-0737-4ABC-9EF5-C4D0FB18C28D Q34321730-91C52BB8-AC5B-40AB-B385-C5E271CCC602 Q34341392-214453E0-A68A-4CC8-890C-0E69F1285297 Q34385843-CEF9549A-414B-48E6-9171-2D6FBD299212 Q34516854-C468AFB8-752E-46A8-9D02-7E5D8D31777B Q34527600-0DC85489-1906-4FEA-8793-E09CF9A5E9C5 Q34529091-7AF06C9A-9BAA-4C71-882B-55776091D59F

P2860

CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1

http://www.wikidata.org/entity/Q28251463

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

CD47 is necessary for inhibiti ...... responses by thrombospondin-1

@ast

CD47 is necessary for inhibiti ...... responses by thrombospondin-1

@en

CD47 is necessary for inhibiti ...... responses by thrombospondin-1

@nl

type

label

CD47 is necessary for inhibiti ...... responses by thrombospondin-1

@ast

CD47 is necessary for inhibiti ...... responses by thrombospondin-1

@en

CD47 is necessary for inhibiti ...... responses by thrombospondin-1

@nl

prefLabel

CD47 is necessary for inhibiti ...... responses by thrombospondin-1

@ast

CD47 is necessary for inhibiti ...... responses by thrombospondin-1

@en

CD47 is necessary for inhibiti ...... responses by thrombospondin-1

@nl

P1433

Q28251463-736B5ECA-3ECE-490C-A08F-FF4E92E830C4

P1476

Q28251463-2783F79B-F1DD-4D64-9B56-C73843694EFE

P2093

Q28251463-036DB2EC-B58A-4C69-BC99-133DA38D4235

Q28251463-24C0396D-425B-4E5C-BA6B-46C849BA4E92

Q28251463-48A0E1B6-5316-4A2E-BC07-CEC8584F8AE4

Q28251463-4DD1B8BF-F50B-4D98-A955-0C081E18BF85

Q28251463-78DA2553-ABE6-429D-A424-4DB8FEEDC485

Q28251463-D5E41E35-6819-4584-BF87-7C1E2D8F00F5

P2860

Q28251463-0E99ED29-59D3-4CCF-B0FC-4DC42E4D88AF

Q28251463-13320A11-0D32-4725-9315-6389477695CD

Q28251463-144C4E80-0A9F-45E1-93FA-BC80699CF692

Q28251463-24C8B173-0BED-4015-8C79-929E317FB0F7

Q28251463-391F3BF1-2307-4225-A11E-7FA06308EF6D

Q28251463-39DE3251-C99F-4BD9-B690-F3DEFB9C48E9

Q28251463-3C7C4F3D-3D6F-4A6B-B5C9-A4481AE058FA

Q28251463-44EE0EFC-CB22-4AAF-B0B5-18DDC11C89BE

Q28251463-481D6600-BC6A-4B25-AAD3-5356AE165B12

Q28251463-4E171562-4282-40CC-87D7-037CC2A70558

P304

Q28251463-40ED9839-7B9A-4D8A-9F7D-C6D7274D61F8

P31

Q28251463-525A6249-8968-423A-9DB1-8110EF689707

P3181

Q28251463-C109FA4B-6072-4054-A742-5239B068010C

P356

Q28251463-B9899458-45AE-41BD-8299-6E979EC04EF8

P407

Q28251463-AC0129FA-9D54-41F4-AB0E-A5B5560C45DB

P433

Q28251463-AE7E69AA-3142-4A3D-A8E4-987E45C52926

P478

Q28251463-C76C6DC3-3440-41F6-8C86-39CE83CEA064

P577

Q28251463-3D7277D3-87C4-4094-8037-CC5CF10D26F2

P698

Q28251463-9EA50077-CB1D-443F-8D46-79BA97B87C6B

P3181

P356

P1433

Journal of Biological Chemistry

P1476

CD47 is necessary for inhibiti ...... responses by thrombospondin-1

@en

P2093

David A Wink

http://www.w3.org/2001/XMLSchema#string

David D Roberts

http://www.w3.org/2001/XMLSchema#string

Jeff S Isenberg

http://www.w3.org/2001/XMLSchema#string

Julie Dimitry

http://www.w3.org/2001/XMLSchema#string

Lisa A Ridnour

http://www.w3.org/2001/XMLSchema#string

William A Frazier

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner

Interactions of thrombospondins with alpha4beta1 integrin and CD47 differentially modulate T cell behavior

Crystal structure of the TSP-1 type 1 repeats

Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats

Lysosomal integral membrane protein II binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif

Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin

Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1

A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen, and GPIIbIIIa receptor.

Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation.

Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1.

P304

26069-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3621083

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M605040200

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

281

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16835222

http://www.w3.org/2001/XMLSchema#string